HPLC Fraction Collection Storage System
Porvair Sciences has announced a complete storage solution for HPLC fractions comprising its 2 mL round deep well microplate and high integrity cap mat seals.
The revolutionary design of the 2 mL deep well plate, which for the first time provides scientists with a genuine 2 mL working volume in a 45 mm height plate, is now coupled with a choice of specially designed cap mats. These flexible, re-usable cap mats prevent evaporation and allow transport and storage of samples in the 2 mL plate without the need for expensive heat seals or leaky adhesive-based seals.
To ensure complete confidence in the integrity of your sealed HPLC autosampler or fraction collector samples, Porvair has included it’s popular, flexible pre-scored silicone cap mats with double O-ring in the package.
For a limited period Porvair Sciences is offering a free pack of 50 cap mats with each order for two or more cases of 50 x 2 mL round well plates, creating a valuable saving for your lab. This offer runs until 30 November 2014 and applies to sales of these products in the European Union only, either via authorised Porvair Distributors or direct from Porvair Sciences at www.microplates.com. Shipping charges and local taxes may apply.
Related News
-
News Pharmaceutical Supply Chain People Moves
The latest appointments, promotions, and structural changes across the pharmaceutical supply chain.
-
News Merck KGaA to buy US biotech SpringWorks for US$3.9 billion
The German multinational pharmaceutical company Merck KGaA have signed a deal to buy US biotech company SpringWorks Therapeutics at an equity value of US$3.9 billion in a move to add rare cancer therapeutics to their pipelines.
-
News Cassava Sciences halts Alzheimer's drug trial after limited progress
Cassava Sciences have drawn a close to their investigations and development of the drug simufilam, which they intended to be used for the treatment of Alzheimer’s disease.
-
News US FDA adds haemodialysis bloodlines to devices shortage list
On March 14, 2025, the US FDA published an open letter to healthcare providers citing continuing supply disruptions of haemodialysis bloodlines, an essential component of dialysis machines.
-
News Vertex Pharmaceuticals stock jumps as FDA approves non-opioid painkiller
UK-based Vertex Pharmaceuticals saw their stock shares soar as the US FDA signed off on the non-opioid painkiller Journavx, also known as suzetrigine, for patients with moderate to severe acute pain, caused by surgery, accidents, or injuries.
-
News Lessons from CPHI Milan 2024: Sunny Intervals for Pharma Manufacturing?
As the 2024 CPHI conference wrapped up in Milan, we caught up with L.E.K. Consulting – a global strategy consulting firm with deep expertise in pharma manufacturing – to discuss evolving market perspectives and business outlook. -
News US BIOSECURE Act passed by US House of Representatives
The controversial act, which has already impacted several foreign companies operating in the US, was passed by the House of Representatives on September 9, 2024. It is now headed for the US Senate before it can be signed into law by President Joe Biden... -
News Drug prices agreed upon as part of the US Inflation Reduction Act
The Inflation Reduction Act brought into constitution by the Biden administation in 2022, which proposed a drug price negotiation between the government and pharmaceutical companies, has reached it's first agreement.